ClinConnect ClinConnect Logo
Search / Trial NCT02528253

A Phase 3 Study of Tanezumab for Chronic Low Back Pain

Launched by PFIZER · Aug 18, 2015

Trial Information

Current as of April 25, 2025

Completed

Keywords

Chronic Low Back Pain Chronic Pain

ClinConnect Summary

This is a randomized, double blind, placebo and active controlled, multicenter, parallel group Phase 3 study of the efficacy and safety of tanezumab when administered by SC injection for up to 56 weeks in subjects with chronic low back pain. Approximately 1800 subjects will be randomized to 1 of 4 treatment groups in a 2:2:2:3 ratio (ie, 400 subjects per treatment group for the placebo, tanezumab 5 mg and tanezumab 10 mg treatment groups and 600 subjects in the tramadol PR treatment group). Treatment groups will include: 1.) Placebo administered SC at an 8 week interval plus placebo matchin...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • -Chronic low back pain ≥3 months in duration, Quebec Task Force in Spinal Disorders class 1 or 2, with documented history of previous inadequate treatment response to at least 3 different categories of agents commonly used and generally considered effective for the treatment of chronic low back pain.
  • Exclusion Criteria:
  • --Diagnosis of osteoarthritis of the knee or hip as defined by the American College of Rheumatology (ACR) criteria.
  • Subjects who have Kellgren Lawrence Grade \> or =2 radiographic evidence of hip or Grade \> or=3 radiographic evidence of knee osteoarthritis will be excluded;
  • History or radiographic evidence of other diseases that could confound efficacy or safety assessments (e.g., rheumatoid arthritis).
  • History or radiographic evidence of orthopedic conditions that may increase the risk of, or confound assessment of joint safety conditions during the study.
  • Signs and symptoms of clinically significant cardiac disease within 6 months of the study (e.g., unstable angina, myocardial infarction, resting bradycardia, poorly controlled or untreated hypertension) as defined in the protocol or subjects with any other cardiovascular illness that in the opinion of the Investigator would render a subject unsuitable to participate in the study
  • History, diagnosis, or signs and symptoms of clinically significant neurological disease (e.g., transient ischemic attack, stroke, peripheral or autonomic neuropathy) as specified in the protocol
  • Subjects with evidence or symptoms consistent with autonomic dysfunction (e.g., orthostatic hypotension and/or autonomic symptoms) as defined in the protocol.

About Pfizer

Pfizer Inc. is a global leader in biopharmaceutical innovation, dedicated to discovering, developing, and delivering advanced therapies that enhance patient outcomes across a wide range of medical conditions. With a rich history of scientific research and a commitment to quality, Pfizer focuses on areas such as oncology, immunology, cardiology, and rare diseases. The company leverages cutting-edge technology and collaborates with healthcare professionals, regulatory bodies, and academic institutions to conduct rigorous clinical trials that ensure the safety and efficacy of its products. Pfizer's mission is to bring breakthroughs that change patients' lives, exemplifying its commitment to health and wellness worldwide.

Locations

Chicago, Illinois, United States

Boston, Massachusetts, United States

Madrid, , Spain

Rochester, New York, United States

Warwick, Rhode Island, United States

Coral Gables, Florida, United States

Albuquerque, New Mexico, United States

Duncansville, Pennsylvania, United States

Walnut Creek, California, United States

Evansville, Indiana, United States

West Palm Beach, Florida, United States

San Antonio, Texas, United States

Chicago, Illinois, United States

Raleigh, North Carolina, United States

Rochester, New York, United States

Seoul, , Korea, Republic Of

Los Angeles, California, United States

Oklahoma City, Oklahoma, United States

Rochester, New York, United States

New Orleans, Louisiana, United States

Winston Salem, North Carolina, United States

Cincinnati, Ohio, United States

Bay City, Michigan, United States

Wheaton, Maryland, United States

Berlin, New Jersey, United States

Mobile, Alabama, United States

Honolulu, Hawaii, United States

Las Vegas, Nevada, United States

Oklahoma City, Oklahoma, United States

Marietta, Georgia, United States

Spring Valley, California, United States

Houston, Texas, United States

Des Moines, Iowa, United States

Fukushima, , Japan

Saint Petersburg, Florida, United States

Jupiter, Florida, United States

Hallandale Beach, Florida, United States

Toyama, , Japan

Cincinnati, Ohio, United States

Seoul, , Korea, Republic Of

Shinjuku Ku, Tokyo, Japan

Hiroshima, , Japan

Stamford, Connecticut, United States

Olive Branch, Mississippi, United States

Omaha, Nebraska, United States

Houston, Texas, United States

Downingtown, Pennsylvania, United States

Fresno, California, United States

Birmingham, Alabama, United States

Little Rock, Arkansas, United States

North Hollywood, California, United States

Valley Village, California, United States

Denver, Colorado, United States

Boynton Beach, Florida, United States

Miami Lakes, Florida, United States

Orlando, Florida, United States

Woodstock, Georgia, United States

Woodstock, Georgia, United States

Franklin, Ohio, United States

Rapid City, South Dakota, United States

Nashville, Tennessee, United States

Newmarket, Ontario, Canada

Sarnia, Ontario, Canada

Seoul, , Korea, Republic Of

Izumisano, Osaka, Japan

Sacramento, California, United States

Santiago De Compostela, A Coruna, Spain

Denver, Colorado, United States

Chestnut Hill, Massachusetts, United States

Albuquerque, New Mexico, United States

Las Vegas, Nevada, United States

Fargo, North Dakota, United States

Jackson, Mississippi, United States

Blue Ridge, Georgia, United States

New Orleans, Louisiana, United States

Lenoir, North Carolina, United States

Oklahoma City, Oklahoma, United States

Atlantis, Florida, United States

Paris Cedex 14, , France

New York, New York, United States

Wildomar, California, United States

Bellevue, Washington, United States

Chula Vista, California, United States

Watertown, Massachusetts, United States

Saint Louis, Missouri, United States

Trenton, New Jersey, United States

Port Orange, Florida, United States

Newnan, Georgia, United States

Ube, Yamaguchi, Japan

Jackson, Mississippi, United States

Seoul, , Korea, Republic Of

Marietta, Georgia, United States

Toledo, Ohio, United States

Richmond, Virginia, United States

Brownsburg, Indiana, United States

Saitama, , Japan

Arlington, Texas, United States

Phoenix, Arizona, United States

Chicago, Illinois, United States

La Mesa, California, United States

Anaheim, California, United States

Szekszard, , Hungary

Newnan, Georgia, United States

Fort Lauderdale, Florida, United States

Hartsdale, New York, United States

Winston Salem, North Carolina, United States

Jacksonville, Florida, United States

Columbus, Georgia, United States

Midlothian, Virginia, United States

Marlton, New Jersey, United States

West Des Moines, Iowa, United States

Kanazawa, Ishikawa, Japan

Tampa, Florida, United States

Nagakute, Aichi, Japan

Charlottesville, Virginia, United States

Scottsdale, Arizona, United States

Cumberland, Maryland, United States

Sarasota, Florida, United States

Columbia, South Carolina, United States

Las Vegas, Nevada, United States

Oklahoma City, Oklahoma, United States

Quebec, , Canada

Boulder, Colorado, United States

El Cajon, California, United States

San Diego, California, United States

Edgewood, Kentucky, United States

Lake Charles, Louisiana, United States

Bellevue, Washington, United States

Birmingham, Alabama, United States

Alicante, , Spain

Phoenix, Arizona, United States

Chicago, Illinois, United States

Deland, Florida, United States

Quincy, Massachusetts, United States

Valparaiso, Indiana, United States

Miami, Florida, United States

Malaga, , Spain

Bridgeport, Connecticut, United States

Chicago, Illinois, United States

Lafayette, Indiana, United States

Wichita, Kansas, United States

Portsmouth, New Hampshire, United States

Hollywood, Florida, United States

Brooklyn, New York, United States

Draper, Utah, United States

Fresno, California, United States

Long Beach, California, United States

Hakodate, Hokkaido, Japan

Shimonoseki Shi, Yamaguchi, Japan

Szekszard, , Hungary

Mesa, Arizona, United States

Cerritos, California, United States

Garden Grove, California, United States

Montclair, California, United States

Miami, Florida, United States

Miami, Florida, United States

Ocoee, Florida, United States

Gainesville, Georgia, United States

Overland Park, Kansas, United States

Rochester Hills, Michigan, United States

Las Vegas, Nevada, United States

Fargo, North Dakota, United States

Centerville, Ohio, United States

Columbus, Ohio, United States

Knoxville, Tennessee, United States

San Antonio, Texas, United States

Funabashi, Chiba, Japan

Himeji, Hyogo, Japan

Kako Gun, Hyogo, Japan

Kobe, Hyogo, Japan

Matsumoto, Nagano, Japan

Fussa, Tokyo, Japan

Shinagawa Ku, Tokyo, Japan

Shinagawa Ku, Tokyo, Japan

Fukuoka, , Japan

Fukuoka, , Japan

Mobile, Alabama, United States

Mobile, Alabama, United States

Mobile, Alabama, United States

Saraland, Alabama, United States

Little Rock, Arkansas, United States

Little Rock, Arkansas, United States

Fresno, California, United States

Los Angeles, California, United States

Milford, Connecticut, United States

Deland, Florida, United States

Miami, Florida, United States

Orlando, Florida, United States

Marietta, Georgia, United States

Savannah, Georgia, United States

Chicago, Illinois, United States

Chicago, Illinois, United States

Chicago, Illinois, United States

Skokie, Illinois, United States

Lafayette, Indiana, United States

Des Moines, Iowa, United States

Des Moines, Iowa, United States

West Des Moines, Iowa, United States

Crestview Hills, Kentucky, United States

Edgewood, Kentucky, United States

Bossier City, Louisiana, United States

Bossier City, Louisiana, United States

Troy, Michigan, United States

Wyoming, Michigan, United States

Somerset, New Jersey, United States

Mooresville, North Carolina, United States

Frgi, North Dakota, United States

Beavercreek, Ohio, United States

Mentor, Ohio, United States

Mentor, Ohio, United States

Greer, South Carolina, United States

North Charleston, South Carolina, United States

Houston, Texas, United States

Plano, Texas, United States

San Antonio, Texas, United States

Sherbrooke, Quebec, Canada

Quebec, , Canada

Hillerod, , Denmark

Bekescsaba, , Hungary

Budapest, , Hungary

Budapest, , Hungary

Kecskemét, , Hungary

Miskolc, , Hungary

Miskolc, , Hungary

Szekszard, , Hungary

Showa Ku, Nagoya, Aichi, Japan

Chuo Ku, Chiba, Chiba, Japan

Ichihara, Chiba, Japan

Wakaba Ku, Chiba, Chiba, Japan

Higashi Ku,Fukuoka, Fukuoka, Japan

Kokuraminami Ku,Kitakyushu, Fukuoka, Japan

Okawa, Fukuoka, Japan

Aizuwakamatsu, Fukushima, Japan

Hakodate, Hokkaido, Japan

Higashinada Ku, Kobe, Hyogo, Japan

Komatsu, Ishikawa, Japan

Beppu, Oita, Japan

Higashiosaka, Osaka, Japan

Suminoe Ku, Osaka, Osaka, Japan

Kumagaya, Saitama, Japan

Hamamatsu, Shizuoka, Japan

Bunkyo Ku, Tokyo, Japan

Minato Ku, Tokyo, Japan

Yonezawa, Yamagata, Japan

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

A Coruna, , Spain

A Coruna, , Spain

Barcelona, , Spain

Barcelona, , Spain

Barcelona, , Spain

Barcelona, , Spain

Barcelona, , Spain

Barcelona, , Spain

Barcelona, , Spain

Barcelona, , Spain

Madrid, , Spain

Madrid, , Spain

Madrid, , Spain

Malaga, , Spain

Gothenburg, , Sweden

Helsingborg, , Sweden

Malmo, , Sweden

Stockholm, , Sweden

Patients applied

0 patients applied

Trial Officials

Pfizer CT.gov Call Center

Study Director

Pfizer

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials